Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Metformin for Tertiary Prevention in Colorectal Cancer
NCT03047837Phase 2Terminated
- Sponsor
- Ospedali Galliera
- Start
- Mar 2017
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, liquid metformin (Aspargo Labs) in colorectal cancer (CRC), sponsored by Ospedali Galliera. Started Mar 2017; status: terminated.
02
Drugs
aspirinliquid metformin (Aspargo Labs)
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03047837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047837.